{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:43:04Z","timestamp":1787002984867,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771521"],"award-info":[{"award-number":["31771521"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402145, 81672582"],"award-info":[{"award-number":["81402145, 81672582"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","award":["Top Talent of Innovative Research Team"],"award-info":[{"award-number":["Top Talent of Innovative Research Team"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","award":["Top Talent of Innovative Research Team"],"award-info":[{"award-number":["Top Talent of Innovative Research Team"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002703","name":"Jiangsu University","doi-asserted-by":"publisher","award":["14JDG011"],"award-info":[{"award-number":["14JDG011"]}],"id":[{"id":"10.13039\/501100002703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002703","name":"Jiangsu University","doi-asserted-by":"publisher","award":["14JDG050"],"award-info":[{"award-number":["14JDG050"]}],"id":[{"id":"10.13039\/501100002703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Partitioning-defective protein 6 (Par6) family proteins have been demonstrated to be closely associated with the occurrence and development of cancers. It is well accepted that dysregulation of epithelial\u2013mesenchymal transition (EMT) greatly contributes to carcinogenesis and metastases of ovarian cancer. So far, the roles of Par6 in EMT of ovarian cancer are not clear. Functional experiments were carried out to study the roles of PARD6A in EMT of ovarian cancer in vitro and in vivo, and EMT pathways potentially affected by PARD6A expression were screened. We found that PARD6A was significantly highly expressed in tissues of ovarian cancer patients in III-IV stages, poorly differentiated or with lymphatic metastases versus I-II stages, moderately or well differentiated, or without lymphatic metastases, respectively. PARD6A knockdown suppressed EMT of SKOV3 and A2780 cells in vitro and ovarian cancer metastasis in vivo, while overexpression of PARD6A promoted EMT in HO8910 and OVCAR8 cells. It was indicated that PARD6A affected EMT of ovarian cancer cells through SNAIL1 signaling pathway and subsequently modulated the expression of VIMENTIN and E-cadherin, which was further confirmed by knockdown and overexpression of SNAIL1 experiments. PARD6A was also demonstrated to regulate expression of SNAIL1 by modulating integrin \u03b21 and ILK proteins, specifically it was shown that the transcription of SNAIL1 was regulated by ILK in this study. In addition, expression of ILK in ovarian cancer tissues was demonstrated to be correlated with tumor stages and lymphatic metastases clinically. In this study, we identified a novel role of PARD6A as an inducer of cell migration and invasion, which is likely to play an important role in metastasis of ovarian cancer. The molecular pathways of EMT mediated by PARD6A-Integrin \u03b21-ILK-SNAIL1 and finally implemented by E-cadherin and VIMENTIN may provide a novel strategy for drug development for ovarian cancer therapy in the near future.<\/jats:p>","DOI":"10.1038\/s41419-022-04756-2","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T23:45:29Z","timestamp":1649115929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Partitioning defective 6 homolog alpha (PARD6A) promotes epithelial\u2013mesenchymal transition via integrin \u03b21-ILK-SNAIL1 pathway in ovarian cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Ziwen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9844-3245","authenticated-orcid":false,"given":"Zhigang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-6305","authenticated-orcid":false,"given":"Hanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"4756_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0092-8674(88)80024-2","volume":"52","author":"KJ Kemphues","year":"1988","unstructured":"Kemphues KJ, Priess JR, Morton DG, Cheng NS. Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell. 1988;52:311\u201320.","journal-title":"Cell"},{"key":"4756_CR2","doi-asserted-by":"publisher","first-page":"894","DOI":"10.18632\/oncoscience.255","volume":"2","author":"E Marques","year":"2015","unstructured":"Marques E, Klefstrom J. Par6 family proteins in cancer. Oncoscience. 2015;2:894\u20135.","journal-title":"Oncoscience"},{"key":"4756_CR3","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1126\/science.1105718","volume":"307","author":"B Ozdamar","year":"2005","unstructured":"Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science. 2005;307:1603\u20139.","journal-title":"Science"},{"key":"4756_CR4","doi-asserted-by":"publisher","first-page":"517.","DOI":"10.1126\/scisignal.aam9899","volume":"11","author":"FA Renschler","year":"2018","unstructured":"Renschler FA, Bruekner SR, Salomon PL, Mukherjee A, Kullmann L, Schutz-Stoffregen MC, et al. Structural basis for the interaction between the cell polarity proteins Par3 and Par6. Sci Signal. 2018;11:517.","journal-title":"Sci Signal"},{"key":"4756_CR5","doi-asserted-by":"publisher","first-page":"6878","DOI":"10.1038\/onc.2008.340","volume":"27","author":"V Aranda","year":"2008","unstructured":"Aranda V, Nolan ME, Muthuswamy SK. Par complex in cancer: a regulator of normal cell polarity joins the dark side. Oncogene. 2008;27:6878\u201387.","journal-title":"Oncogene"},{"key":"4756_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/febs.15754","volume":"289","author":"BJ Thompson","year":"2022","unstructured":"Thompson BJ. Par-3 family proteins in cell polarity & adhesion. FEBS J. 2022;289:596\u2013613.","journal-title":"FEBS J"},{"key":"4756_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.bbamem.2007.08.029","volume":"1778","author":"E Assemat","year":"2008","unstructured":"Assemat E, Bazellieres E, Pallesi-Pocachard E, Le Bivic A, Massey-Harroche D. Polarity complex proteins. Biochim Biophys Acta. 2008;1778:614\u201330.","journal-title":"Biochim Biophys Acta"},{"key":"4756_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1096\/fj.201901629RR","volume":"34","author":"P Liu","year":"2020","unstructured":"Liu P, Zhu C, Luo J, Lan S, Su D, Wang Q, et al. Par6 regulates cell cycle progression through enhancement of Akt\/PI3K\/GSK-3beta signaling pathway activation in glioma. FASEB J. 2020;34:1481\u201396.","journal-title":"FASEB J"},{"key":"4756_CR9","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.1158\/0008-5472.CAN-07-6567","volume":"68","author":"ME Nolan","year":"2008","unstructured":"Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, Allred DC, et al. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res. 2008;68:8201\u20139.","journal-title":"Cancer Res"},{"key":"4756_CR10","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1101\/gad.225334.113","volume":"27","author":"JH Tsai","year":"2013","unstructured":"Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27:2192\u2013206.","journal-title":"Genes Dev"},{"key":"4756_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Investig. 2009;119:1420\u20138.","journal-title":"J Clin Investig."},{"key":"4756_CR12","doi-asserted-by":"crossref","unstructured":"Gunaratne A, Thai BL, Di Guglielmo GM. Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor beta-induced epithelial-to-mesenchymal transition. Mol Cell Biol. 2013;33:874\u201386.","DOI":"10.1128\/MCB.00837-12"},{"key":"4756_CR13","doi-asserted-by":"publisher","first-page":"14028","DOI":"10.1073\/pnas.0906796106","volume":"106","author":"AM Viloria-Petit","year":"2009","unstructured":"Viloria-Petit AM, David L, Jia JY, Erdemir T, Bane AL, Pinnaduwage D, et al. A role for the TGFbeta-Par6 polarity pathway in breast cancer progression. Proc Natl Acad Sci USA. 2009;106:14028\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4756_CR14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/bjc.2015.71","volume":"112","author":"Y Mu","year":"2015","unstructured":"Mu Y, Zang G, Engstrom U, Busch C, Landstrom M. TGFbeta-induced phosphorylation of Par6 promotes migration and invasion in prostate cancer cells. Br J Cancer. 2015;112:1223\u201331.","journal-title":"Br J Cancer"},{"key":"4756_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/onc.2015.184","volume":"35","author":"K Zhang","year":"2016","unstructured":"Zhang K, Zhao H, Ji Z, Zhang C, Zhou P, Wang L, et al. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3\/PAR6\/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition. Oncogene. 2016;35:1271\u201382.","journal-title":"Oncogene"},{"key":"4756_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cellsig.2017.06.016","volume":"38","author":"Q Zhou","year":"2017","unstructured":"Zhou Q, Dai J, Chen T, Dada LA, Zhang X, Zhang W, et al. Downregulation of PKCzeta\/Pard3\/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion. Cell Signal. 2017;38:49\u201359.","journal-title":"Cell Signal"},{"key":"4756_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977\u20131010.","journal-title":"Lancet"},{"key":"4756_CR18","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941\u201353.","journal-title":"Int J Cancer"},{"key":"4756_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fonc.2013.00256","volume":"3","author":"N Ahmed","year":"2013","unstructured":"Ahmed N, Stenvers KL. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol. 2013;3:256.","journal-title":"Front Oncol"},{"key":"4756_CR20","doi-asserted-by":"publisher","first-page":"838.","DOI":"10.3390\/cancers11060838","volume":"11","author":"N Loret","year":"2019","unstructured":"Loret N, Denys H, Tummers P, Berx G. The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance. Cancers. 2019;11:838.","journal-title":"Cancers"},{"key":"4756_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fonc.2012.00033","volume":"2","author":"B Davidson","year":"2012","unstructured":"Davidson B, Trope CG, Reich R. Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol. 2012;2:33.","journal-title":"Front Oncol"},{"key":"4756_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-91","volume":"12","author":"AM Haslehurst","year":"2012","unstructured":"Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, et al. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer. 2012;12:91.","journal-title":"BMC Cancer"},{"key":"4756_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/onc.2015.84","volume":"35","author":"X Zhu","year":"2016","unstructured":"Zhu X, Shen H, Yin X, Long L, Xie C, Liu Y, et al. miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin. Oncogene. 2016;35:323\u201332.","journal-title":"Oncogene"},{"key":"4756_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-6-49","volume":"6","author":"LN Lili","year":"2013","unstructured":"Lili LN, Matyunina LV, Walker LD, Wells SL, Benigno BB, McDonald JF. Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis. J Ovarian Res. 2013;6:49.","journal-title":"J Ovarian Res"},{"key":"4756_CR25","doi-asserted-by":"publisher","first-page":"9423907","DOI":"10.1155\/2019\/9423907","volume":"2019","author":"C Scheau","year":"2019","unstructured":"Scheau C, Badarau IA, Costache R, Caruntu C, Mihai GL, Didilescu AC, et al. The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma. Anal Cell Pathol. 2019;2019:9423907.","journal-title":"Anal Cell Pathol"},{"key":"4756_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fmolb.2020.00036","volume":"7","author":"S Drapela","year":"2020","unstructured":"Drapela S, Bouchal J, Jolly MK, Culig Z, Soucek K. ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance. Front Mol Biosci. 2020;7:36.","journal-title":"Front Mol Biosci"},{"key":"4756_CR27","doi-asserted-by":"publisher","first-page":"1040.","DOI":"10.3390\/cells9041040","volume":"9","author":"M Sommariva","year":"2020","unstructured":"Sommariva M, Gagliano N. E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT. Cells. 2020;9:1040.","journal-title":"Cells"},{"key":"4756_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.09.002","volume":"183","author":"S Jansen","year":"2018","unstructured":"Jansen S, Gosens R, Wieland T, Schmidt M. Paving the Rho in cancer metastasis: Rho GTPases and beyond. Pharm Ther. 2018;183:1\u201321.","journal-title":"Pharm Ther."},{"key":"4756_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.archoralbio.2004.05.007","volume":"49","author":"A Nawshad","year":"2004","unstructured":"Nawshad A, LaGamba D, Hay ED. Transforming growth factor beta (TGFbeta) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch Oral Biol. 2004;49:675\u201389.","journal-title":"Arch Oral Biol."},{"key":"4756_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fonc.2020.00499","volume":"10","author":"I Georgakopoulos-Soares","year":"2020","unstructured":"Georgakopoulos-Soares I, Chartoumpekis DV, Kyriazopoulou V, Zaravinos A. EMT Factors and Metabolic Pathways in Cancer. Front Oncol. 2020;10:499.","journal-title":"Front Oncol."},{"key":"4756_CR31","doi-asserted-by":"crossref","unstructured":"Kaufhold S, Bonavida B. Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res. 2014;33:62.","DOI":"10.1186\/s13046-014-0062-0"},{"key":"4756_CR32","doi-asserted-by":"crossref","unstructured":"Goossens S, Vandamme N, Van Vlierberghe P, Berx G. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET. Biochim Biophys Acta Rev Cancer. 2017;1868:584\u201391.","DOI":"10.1016\/j.bbcan.2017.06.006"},{"key":"4756_CR33","doi-asserted-by":"crossref","unstructured":"Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer. 2016;15:18.","DOI":"10.1186\/s12943-016-0502-x"},{"key":"4756_CR34","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1007\/s00018-012-1122-2","volume":"69","author":"E Sanchez-Tillo","year":"2012","unstructured":"Sanchez-Tillo E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, et al. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 2012;69:3429\u201356.","journal-title":"Cell Mol Life Sci"},{"key":"4756_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"4756_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00418-012-0915-6","volume":"137","author":"JO Shin","year":"2012","unstructured":"Shin JO, Nakagawa E, Kim EJ, Cho KW, Lee JM, Cho SW, et al. miR-200b regulates cell migration via Zeb family during mouse palate development. Histochem Cell Biol. 2012;137:459\u201370.","journal-title":"Histochem Cell Biol."},{"key":"4756_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69\u201384.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"4756_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu W, Kang Y. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis. Dev Cell. 2019;49:361\u201374.","journal-title":"Dev Cell."},{"key":"4756_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","volume":"28","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Christofori GEMT. the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28:15\u201333.","journal-title":"Cancer Metastasis Rev."},{"key":"4756_CR40","doi-asserted-by":"crossref","first-page":"3519.","DOI":"10.3390\/ijms22073519","volume":"22","author":"E Kang","year":"2021","unstructured":"Kang E, Seo J, Yoon H, Cho S. The Post-Translational Regulation of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis. Int J Mol Sci. 2021;22:3519.","journal-title":"Int J Mol Sci"},{"key":"4756_CR41","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00018-019-03398-6","volume":"77","author":"W Hua","year":"2020","unstructured":"Hua W, Ten Dijke P, Kostidis S, Giera M, Hornsveld M. TGFbeta-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer. Cell Mol Life Sci. 2020;77:2103\u201323.","journal-title":"Cell Mol Life Sci."},{"key":"4756_CR42","first-page":"1187","volume":"41","author":"H Skovierova","year":"2018","unstructured":"Skovierova H, Okajcekova T, Strnadel J, Vidomanova E, Halasova E. Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review). Int J Mol Med. 2018;41:1187\u2013200.","journal-title":"Int J Mol Med."},{"key":"4756_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-019-0257-6","volume":"14","author":"J Bai","year":"2019","unstructured":"Bai J, Kwok WC, Thiery JP. Traditional Chinese Medicine and regulatory roles on epithelial-mesenchymal transitions. Chin Med. 2019;14:34.","journal-title":"Chin Med"},{"key":"4756_CR44","doi-asserted-by":"crossref","unstructured":"Cannito S, Novo E, di Bonzo LV, Busletta C, Colombatto S, Parola M. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid Redox Signal. 2010;12:1383\u2013430.","DOI":"10.1089\/ars.2009.2737"},{"key":"4756_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76\u201383.","journal-title":"Nat Cell Biol."},{"key":"4756_CR46","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.3892\/mmr.2015.4443","volume":"12","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zou W. Inhibition of integrin beta1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK\/STAT1 signaling pathway. Mol Med Rep. 2015;12:7869\u201376.","journal-title":"Mol Med Rep."},{"key":"4756_CR47","doi-asserted-by":"crossref","unstructured":"Tchaicha JH, Reyes SB, Shin J, Hossain MG, Lang FF, McCarty JH. Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by beta8 integrin. Cancer Res. 2011;71:6371\u201381.","DOI":"10.1158\/0008-5472.CAN-11-0991"},{"key":"4756_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc1524","volume":"5","author":"G Hannigan","year":"2005","unstructured":"Hannigan G, Troussard AA, Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer. 2005;5:51\u201363.","journal-title":"Nat Rev Cancer."},{"key":"4756_CR49","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ki.2010.137","volume":"78","author":"YS Kang","year":"2010","unstructured":"Kang YS, Li Y, Dai C, Kiss LP, Wu C, Liu Y. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int. 2010;78:363\u201373.","journal-title":"Kidney Int."},{"key":"4756_CR50","doi-asserted-by":"publisher","first-page":"e16984","DOI":"10.1371\/journal.pone.0016984","volume":"6","author":"J Chan","year":"2011","unstructured":"Chan J, Ko FC, Yeung YS, Ng IO, Yam JW. Integrin-linked kinase overexpression and its oncogenic role in promoting tumorigenicity of hepatocellular carcinoma. PLoS One. 2011;6:e16984.","journal-title":"PLoS One"},{"key":"4756_CR51","doi-asserted-by":"publisher","first-page":"11211","DOI":"10.1073\/pnas.95.19.11211","volume":"95","author":"M Delcommenne","year":"1998","unstructured":"Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B\/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA. 1998;95:11211\u20136.","journal-title":"Proc Natl Acad Sci USA."},{"key":"4756_CR52","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/jcp.21774","volume":"220","author":"D Lossner","year":"2009","unstructured":"Lossner D, Abou-Ajram C, Benge A, Aumercier M, Schmitt M, Reuning U. Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription. J Cell Physiol. 2009;220:367\u201375.","journal-title":"J Cell Physiol."},{"key":"4756_CR53","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1038\/sj.onc.1207990","volume":"23","author":"MJ Barbera","year":"2004","unstructured":"Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, Peiro S, et al. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene. 2004;23:7345\u201354.","journal-title":"Oncogene."},{"key":"4756_CR54","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/1440-1681.12794","volume":"44","author":"L Ruan","year":"2017","unstructured":"Ruan L, Shen Y, Lu Z, Shang D, Zhao Z, Lu Y, et al. Roles of partitioning-defective protein 6 (Par6) and its complexes in the proliferation, migration and invasion of cancer cells. Clin Exp Pharm Physiol. 2017;44:909\u201313.","journal-title":"Clin Exp Pharm Physiol."},{"key":"4756_CR55","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1038\/onc.2008.119","volume":"27","author":"LA Frederick","year":"2008","unstructured":"Frederick LA, Matthews JA, Jamieson L, Justilien V, Thompson EA, Radisky DC, et al. Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer. Oncogene. 2008;27:4841\u201353.","journal-title":"Oncogene."},{"key":"4756_CR56","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1038\/onc.2009.217","volume":"28","author":"V Justilien","year":"2009","unstructured":"Justilien V, Fields AP. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene. 2009;28:3597\u2013607.","journal-title":"Oncogene."},{"key":"4756_CR57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00774-015-0680-4","volume":"34","author":"G Mendonca Monteiro de Barros","year":"2016","unstructured":"Mendonca Monteiro de Barros G, Madeira M, Vieira Neto L, de Paula Paranhos Neto F, Carvalho Mendonca LM, Correa Barbosa Lima I, et al. Bone mineral density and bone microarchitecture after long-term suppressive levothyroxine treatment of differentiated thyroid carcinoma in young adult patients. J Bone Min Metab. 2016;34:417\u201321.","journal-title":"J Bone Min Metab."},{"key":"4756_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2929-2","volume":"16","author":"H Nakamura","year":"2016","unstructured":"Nakamura H, Nagasaka K, Kawana K, Taguchi A, Uehara Y, Yoshida M, et al. Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer. BMC Cancer. 2016;16:897.","journal-title":"BMC Cancer."},{"key":"4756_CR59","first-page":"383","volume":"11","author":"M Katoh","year":"2003","unstructured":"Katoh M, Katoh M. Identification and characterization of human SNAIL3 (SNAI3) gene in silico. Int J Mol Med. 2003;11:383\u20138.","journal-title":"Int J Mol Med."},{"key":"4756_CR60","doi-asserted-by":"crossref","unstructured":"Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, et al. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer. 2005;103:1631\u201343.","DOI":"10.1002\/cncr.20946"},{"key":"4756_CR61","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00428-006-0274-6","volume":"449","author":"S Elloul","year":"2006","unstructured":"Elloul S, Silins I, Trope CG, Benshushan A, Davidson B, Reich R. Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch. 2006;449:520\u20138.","journal-title":"Virchows Arch."},{"key":"4756_CR62","doi-asserted-by":"crossref","unstructured":"Cordes N. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity. Cancer Res. 2004;64:5683\u201392.","DOI":"10.1158\/0008-5472.CAN-04-1056"},{"key":"4756_CR63","doi-asserted-by":"crossref","unstructured":"Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol. 2003;201:229\u201337.","DOI":"10.1002\/path.1441"},{"key":"4756_CR64","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/sj.onc.1206347","volume":"22","author":"S Cruet-Hennequart","year":"2003","unstructured":"Cruet-Hennequart S, Maubant S, Luis J, Gauduchon P, Staedel C, Dedhar S. alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene. 2003;22:1688\u2013702.","journal-title":"Oncogene."},{"key":"4756_CR65","doi-asserted-by":"publisher","first-page":"246.","DOI":"10.3390\/jpm10040246","volume":"10","author":"MA Ulm","year":"2020","unstructured":"Ulm MA, Redfern TM, Wilson BR, Ponnusamy S, Asemota S, Blackburn PW, et al. Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer. J Pers Med. 2020;10:246.","journal-title":"J Pers Med"},{"key":"4756_CR66","doi-asserted-by":"publisher","first-page":"880.","DOI":"10.3390\/cancers12040880","volume":"12","author":"JM Reyes-Gonzalez","year":"2020","unstructured":"Reyes-Gonzalez JM, Quinones-Diaz BI, Santana Y, Baez-Vega PM, Soto D, Valiyeva F, et al. Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer. Cancers. 2020;12:880.","journal-title":"Cancers"},{"key":"4756_CR67","doi-asserted-by":"publisher","first-page":"108800","DOI":"10.1016\/j.celrep.2021.108800","volume":"34","author":"I Masi","year":"2021","unstructured":"Masi I, Caprara V, Spadaro F, Chellini L, Sestito R, Zancla A, et al. Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK. Cell Rep. 2021;34:108800.","journal-title":"Cell Rep."},{"key":"4756_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1101-0","volume":"9","author":"X Wu","year":"2018","unstructured":"Wu X, Zhao J, Ruan Y, Sun L, Xu C, Jiang H. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-beta1-induced EMT and confers paclitaxel resistance in ovarian cancer. Cell Death Dis. 2018;9:1102.","journal-title":"Cell Death Dis."},{"key":"4756_CR69","doi-asserted-by":"crossref","unstructured":"Muscella A, Calabriso N, Vetrugno C, Urso L, Fanizzi FP, De Pascali SA, et al. Sublethal concentrations of the platinum(II) complex [Pt(O,O\u2019-acac)(gamma-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells. Br J Pharmacol. 2010;160:1362\u201377.","DOI":"10.1111\/j.1476-5381.2010.00782.x"},{"key":"4756_CR70","doi-asserted-by":"publisher","first-page":"e1595","DOI":"10.1038\/cddis.2014.555","volume":"6","author":"H Liu","year":"2015","unstructured":"Liu H, Lu J, Hua Y, Zhang P, Liang Z, Ruan L, et al. Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer. Cell Death Dis. 2015;6:e1595.","journal-title":"Cell Death Dis"},{"key":"4756_CR71","doi-asserted-by":"publisher","first-page":"e13145","DOI":"10.1111\/acel.13145","volume":"19","author":"D Shang","year":"2020","unstructured":"Shang D, Sun D, Shi C, Xu J, Shen M, Hu X, et al. Activation of epidermal growth factor receptor signaling mediates cellular senescence induced by certain pro-inflammatory cytokines. Aging Cell. 2020;19:e13145.","journal-title":"Aging Cell."},{"key":"4756_CR72","doi-asserted-by":"publisher","first-page":"100996","DOI":"10.1016\/j.jbc.2021.100996","volume":"297","author":"H Liu","year":"2021","unstructured":"Liu H, Lu Z, Shi X, Liu L, Zhang P, Golemis EA, et al. HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression. J Biol Chem. 2021;297:100996.","journal-title":"J Biol Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04756-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04756-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04756-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:59:20Z","timestamp":1669283960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04756-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":72,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["4756"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04756-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"23 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Medical Ethics Committee of Jiangsu University. All patients provided signed written informed consent. Animal experiments were approved by the Animal Ethics Committee of Jiangsu University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"304"}}